ExeVir
Description: ExeVir develops single-domain antibody therapies for viral infections, with XVR011 targeting COVID-19 as both a therapeutic and prophylactic.
Country: Belgium
Based in: Zwijnaarde
Founded: 2020
Funding Stage: Series A/B
Tags: ['Biotechnology', 'Health Care', 'Life Science', 'Therapeutics']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
